0
0

Affordable Drug Manufacturing Act of 2020

2/8/2022, 11:22 PM

Congressional Summary of S 3162

Affordable Drug Manufacturing Act of 2020

This bill establishes the Office of Drug Manufacturing within the Department of Health and Human Services to lower prices for, increase access to, and address shortages of prescription drugs (e.g., insulin, naloxone, and antibiotics), including by manufacturing prescription drugs and selling them at a fair price.

Current Status of Bill S 3162

Bill S 3162 is currently in the status of Bill Introduced since January 8, 2020. Bill S 3162 was introduced during Congress 116 and was introduced to the Senate on January 8, 2020.  Bill S 3162's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of January 8, 2020

Bipartisan Support of Bill S 3162

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 3162

Primary Policy Focus

Health

Potential Impact Areas

- Competition and antitrust
- Congressional oversight
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Executive agency funding and structure
- Federal officials
- Government employee pay, benefits, personnel management
- Health care costs and insurance
- Health care coverage and access
- Health care quality
- Health programs administration and funding
- Inflation and prices
- Licensing and registrations
- Manufacturing
- Prescription drugs
- Public contracts and procurement
- Public participation and lobbying

Alternate Title(s) of Bill S 3162

Affordable Drug Manufacturing Act of 2020
Affordable Drug Manufacturing Act of 2020
A bill to amend the Public Health Service Act to establish an Office of Drug Manufacturing.

Comments